[Idiopathic choroidal neovascularization in children]
Patrycja Krzyzanowska-Berkowska1, Karolina Agopsowicz-Spławska, Anna Barć
1Z Katedry i Kliniki Okulistyki Akademii Medycznej we Wroctawiu. p_krzyzanowska@wp.pl
Insights
Idiopathic choroidal neovascularization (CNV) in children is a rare cause of vision loss. This study observed four untreated boys with idiopathic CNV, highlighting potential treatment options.
Area of Science:
- Ophthalmology
- Pediatrics
- Medical Research
Background:
- Idiopathic choroidal neovascularization (CNV) is an uncommon yet significant cause of visual impairment in pediatric patients.
- Early diagnosis and understanding of idiopathic CNV are crucial for managing vision loss in children.
Observation:
- The study presents a one-year clinical observation of four pediatric cases (boys aged 6-13) with unilateral visual deterioration.
- Idiopathic CNV was diagnosed through comprehensive ophthalmological examinations, including fundus photography, OCT, FA, and laboratory tests to rule out systemic diseases.
Findings:
- All four pediatric cases of idiopathic CNV were managed without active treatment during the observation period.
- The natural course and progression of untreated idiopathic CNV in this cohort were monitored.
Implications:
- This case series provides insights into the clinical course of untreated idiopathic CNV in children.
- The discussion reviews various therapeutic strategies, including laser therapy, PDT, surgery, and anti-VEGF injections, for potential future management.
Abstract:
Idiopathic choroidal neovascularization (CNV) in children is a rare, but important cause of visual impairment. Purpose of this paper is to report one year clinical observation of 4 children with idiopathic choroidal neovascularization. Authors present 4 cases of CNV in boys at 6-13 years old, with unilateral visual deterioration onset. All cases were diagnosed as idiopathic ones after pediatric and ophthalmological examination including fundus color photographs and optical coherence tomography (OCT) in all cases, fluorescein angiography (FA) in 2 cases, as well as laboratory tests to exclude the systemic diseases. All cases were left untreated. This presentation discusses therapeutic management according to the argon laser therapy, photodynamic therapy, submacular surgery and intravitreal injection of anti-VEGF.
Related Concept Videos
Diabetic Retinopathy
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview


